HCA Healthcare, Inc.
HCA
Clasificación en acciones
#233
HCA Healthcare, Inc., operating through its subsidiaries, delivers a... HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.
Precio por acción
$455.61
Última sincronización: 2026-10-19
Capitalización bursátil
$98.64B
Cambio (1 día)
-0.42%
Cambio (1 año)
5.19%
País
US
Comercio HCA Healthcare, Inc. (HCA)
Categoría
Healthcare
Ratio P/E de HCA Healthcare, Inc. (HCA)
Ratio P/E al October 2026 TTM: 15.70
Según los últimos informes financieros y el precio de las acciones de HCA Healthcare, Inc., el P/E actual (TTM) de la empresa es 15.70. Al final de 2024, la empresa tenía un P/E de 13.48.
Historial del ratio P/E de HCA Healthcare, Inc. desde 2000 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 15.70 | -1.12% |
| 2025 | 15.88 | 17.82% |
| 2024 | 13.48 | -4.20% |
| 2023 | 14.07 | 13.93% |
| 2022 | 12.35 | 3.39% |
| 2021 | 11.94 | -19.42% |
| 2020 | 14.82 | 2.99% |
| 2019 | 14.39 | 27.70% |
| 2018 | 11.27 | -18.80% |
| 2017 | 13.88 | 46.23% |
| 2016 | 9.49 | -25.08% |
| 2015 | 12.67 | -23.04% |
| 2014 | 16.46 | 22.10% |
| 2013 | 13.48 | 61.79% |
| 2012 | 8.33 | 95.59% |
| 2011 | 4.26 | -61.13% |
| 2010 | 10.96 | 8.90% |
| 2009 | 10.06 | -36.15% |
| 2008 | 15.76 | 29.87% |
| 2007 | 12.14 | 0.47% |
| 2006 | 12.08 | 26.01% |
| 2005 | 9.59 | -19.05% |
| 2004 | 11.84 | 1.54% |
| 2003 | 11.66 | -38.72% |
| 2002 | 19.03 | 3.68% |
| 2001 | 18.36 | -76.33% |
| 2000 | 77.55 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| - | - |
DE
|
|
| 10.40 | -33.78% |
US
|
|
| 32.07 | 104.23% |
SA
|
|
| 20.00 | 27.37% |
BR
|
|
| - | - |
MY
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.